Oramed Pharmaceuticals (ORMP) Stock Chart & Stock Price History $2.45 +0.01 (+0.41%) As of 01/6/2025 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Oramed Pharmaceuticals Stock Price Performance 5 Day Performance+1.66%1 Month Performance+2.08%3 Month Performance+1.66%6 Month Performance-4.30%Year-To-Date Performance+1.24%1 Year Performance-0.81% Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. Email Address What’s 2025’s Best-Kept Stock Secret? (Ad) Have you heard about the stock that’s set to make waves in 2025? In a year marked by increasing digital threats and the demand for robust cybersecurity solutions, one company is positioning itself as a standout performer. The surge in cyberattacks and the need for advanced security measures are reshaping how businesses protect their data and infrastructure. Identifying the right stock to hold onto has never been more crucial. What’s the buzz about?We’re excited to unveil our exclusive report on 2025’s #1 Buy & Hold Stock ORMP Stock Chart for Tuesday, January, 7, 2025 ORMP Chart by TradingView Oramed Pharmaceuticals Stock Price History Daily Weekly Monthly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year Time Frame * Start Date * End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization01/06/2025$2.44$2.45+0.41%$2.47$2.4079,707 shs$98.76 million01/03/2025$2.41$2.44+1.24%$2.50$2.4095,571 shs$98.36 million01/02/2025$2.42$2.41-0.41%$2.46$2.3988,525 shs$97.15 million01/01/2025$2.42$2.42$2.44$2.32450,824 shs$97.56 million12/31/2024$2.33$2.42+3.86%$2.44$2.32450,824 shs$97.56 million12/30/2024$2.37$2.33-1.69%$2.40$2.33213,027 shs$93.93 million Get the Latest News and Ratings for ORMP and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. 12/27/2024$2.36$2.37+0.42%$2.40$2.35126,390 shs$95.54 million12/26/2024$2.38$2.36-0.84%$2.38$2.35118,983 shs$95.14 million12/25/2024$2.38$2.38$2.40$2.3561,649 shs$95.94 million12/24/2024$2.38$2.38$2.40$2.3561,649 shs$95.94 million12/23/2024$2.37$2.38+0.42%$2.41$2.34169,075 shs$95.94 million12/20/2024$2.49$2.37-4.82%$2.49$2.37100,535 shs$95.54 million12/19/2024$2.40$2.49+3.75%$2.51$2.38248,408 shs$100.38 million12/18/2024$2.35$2.40+2.13%$2.50$2.35334,565 shs$96.75 million12/17/2024$2.39$2.35-1.67%$2.41$2.31288,866 shs$94.73 million12/16/2024$2.47$2.39-3.24%$2.51$2.37163,625 shs$96.34 million12/13/2024$2.49$2.47-0.80%$2.49$2.45121,495 shs$99.57 million12/12/2024$2.46$2.49+1.22%$2.49$2.45158,176 shs$100.37 million12/11/2024$2.51$2.46-1.99%$2.50$2.43175,549 shs$99.16 million12/10/2024$2.52$2.51-0.40%$2.56$2.49252,755 shs$101.18 million12/09/2024$2.40$2.52+5.00%$2.52$2.41161,582 shs$101.58 million12/06/2024$2.51$2.40-4.38%$2.51$2.37266,890 shs$96.74 million Related Companies Contineum Therapeutics Stock Chart REGENXBIO Stock Chart Alumis Stock Chart Sana Biotechnology Stock Chart IGM Biosciences Stock Chart Korro Bio Stock Chart Design Therapeutics Stock Chart Y-mAbs Therapeutics Stock Chart Valneva Stock Chart Taysha Gene Therapies Stock Chart Receive ORMP Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Oramed Pharmaceuticals and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:ORMP) was last updated on 1/7/2025 by MarketBeat.com Staff From Our Partners Is Starlink Set For The Largest IPO In History?He turned PayPal from a tiny, off-the-radar startup… to a massive $64 billion giant. Then, he did it again ...Paradigm Press | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode in 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredKamala’s final humiliation The investments connected to Trump's second term in ways that almost nobody outside his inner circle is aware ...Porter & Company | SponsoredCollect $7k per month from Tesla’s SECRET dividendTesla doesn't pay a traditional dividend.... But I just discovered a secret backdoor to collect a secret 69...Investors Alley | Sponsored⭕ [URGENT] Buy Alert just triggeredMy absolute favorite stock just hit a critical "buy now" trigger price.Behind the Markets | SponsoredElon Musk says U.S. government is going bankruptIn 2016, Jeff Brown called Nvidia at a split-adjusted 66 cents. The company just became the world's third $...Brownstone Research | SponsoredBuy this coin BEFORE Inauguration Day …Mark my words … Bitcoin is going to $100,000. BEFORE Trump is inaugurated. And I think it could reach $1...Weiss Ratings | SponsoredTrading 5-7 Stocks to Profit $1,300 a Day?If you want a straightforward, faster, and potentially more reliable way to trade… Learn this strategy by w...Prosper Trading Academy | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oramed Pharmaceuticals Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oramed Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
